ASH Research Collaborative Announces 2026 Call for Research Proposals Awardees
ASH Research Collaborative® (ASH RC) Awards Four Investigator-Led Projects to Advance Real-World Multiple Myeloma Research
Entries by admin
ASH Research Collaborative Expands Its Research Network into Community Settings
The ASH Research Collaborative® (ASH RC) Multiple Myeloma Research Network is pleased to announce the recipients of the Multiple Myeloma Data Hub Award.
ASH Research Collaborative Funds Three Sickle Cell Disease Research Projects
The ASH Research Collaborative (ASH RC) funded three research projects which will leverage the Sickle Cell Disease (SCD) Research Network to improve quality of care, quality of life, and access to effective treatments for people living with SCD.
Sickle Cell Disease (SCD) Data Hub Award
The ASH Research Collaborative (ASH RC) Sickle Cell Disease (SCD) Research Network is excited to announce the launch of an SCD Data Hub Award Request for Proposal Applications (RPA).
The ASH Research Collaborative Sickle Cell Disease Research Network: past, present, and future
This report details the initiative’s mission, history, achievements to date, and its promising trajectory toward improving the lives of individuals affected by Sickle Cell Disease.
ASH Research Collaborative Announces New Board Leadership and New Directors
The ASH Research Collaborative (ASH RC) welcomes new directors to its Board of Directors and announces updates to Board leadership, effective January 1, 2026.
ASH Research Collaborative Selects Five Recipients of SCD Data Hub Award
Five early-career investigators are the recipients of the ASH RC SCD Data Hub Award, which is designed to support the next generation of SCD researchers. Under this award, advanced career SCD researchers will partner with and serve as dedicated mentors to early career investigators through every stage of project development, from concept to study completion.
Automated Approach Uses ASH RC Data to Classify Sickle Cell Disease by Similar Genotype
A new study based on multi-site data from the ASH Research Collaborative (ASH RC) Data Hub showcases an automated approach to subclassifying similar genotypes of sickle cell disease using data from electronic health records.
Real-World Analysis of Voxelotor Outcomes Finds No Clear Sign of Harm, But No Real Benefits
New data finds that the sickle cell drug voxelotor was not associated with any clear indicator of harm to patients, but had limited benefits overall. The findings were based on data pulled from the ASH Research Collaborative (ASH RC) Data Hub.
Using Conventional Definitions, Some High-Risk Multiple Myeloma Patients May Be Missed
Research using data from the ASH Research Collaborative (ASH RC) Data Hub aims to define “functional high-risk” multiple myeloma, suggesting that newly diagnosed patients whose disease progresses within 30 months of a triplet or quadruplet drug regimen have poorer outcomes than those who progress after 30 months.
ASH RESEARCH COLLABORATIVE
The ASH Research Collaborative (ASH RC) is a non-profit organization established by the American Society of Hematology (ASH) in 2017 to improve the lives of people affected by blood diseases by fostering collaborative partnerships to accelerate progress in hematology. Learn more about ASH RC